FWCC-Biorepository, United States

Registration Status: Pending

Objective: The biorepository, a Feist-Weiller Cancer Center (FWCC) supported resource, provides a gateway through which investigators, involved in an IRB-approved research project or clinical trial, can acquire human tissue samples and/or hematological specimens to support their research. The overall goal of FWCC – Biorepository is to support translational research by functioning as the primary fresh-frozen tissue acquisition and processing facility for human solid tissue and hematopoietic specimens. In support of future research studies, the FWCC Biorepository utilizes an IRB-approved protocol to procure remnant tissue, blood, or other body fluids from consented patients for research purposes. Additionally, FWCC – Biorepository provides customized services and equipment to assist investigators in the procurement, analyses, and clinicopathologic correlation of human tissue specimens.

Registered Biobank Name FWCC-Biorepository
Biobank Leader Jimi Murph
Country United States
Email for biobank inquiries jimi.murph@lsuhs.edu
Principal Investigator Ellen Friday, PhD, QBRS(ASCP)cm
Website
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected:
Cohort Highlights